Salix Pharmaceuticals (SLXP) Soars on Acquisition Offer

Shares of Raleigh, North Carolina, based Salix Pharmaceuticals Ltd. (SLXP) rose sharply on Tuesday, after a report that Allergan Inc. (AGN) approached it as an acquisition target. Salix stock was up 15.54%, rising $21.63 per share to close at $160.80, on volume of 6,764,888 shares. The stock closed at its highest level since 2000 on Read the full article... Read the rest of Salix Pharmaceuticals (SLXP) Soars on Acquisition Offer at InvestorGuide.com .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.